Cardiothoracic & vascular anesthesia

Incidence and Associated Patient Characteristics of Gastrointestinal Bleeding Following Transesophageal Echocardiography in Transcatheter Structural Heart Interventions and Cardiac Surgery: A Descriptive Epidemiological Study

J Cardiothorac Vasc AnesthPublished Descriptive epidemiological study

Authors' conclusion

Using identical diagnostic criteria, this study demonstrates similar incidence proportions of UGIB in the SHI and cardiac surgery cohorts, with approximately half of cases presenting within 3 days.

Study context

Population
Adults ≥18 years undergoing SHI or cardiac surgery with same-day transesophageal echocardiography (TEE), JMDC hospital database, April 2014–December 2023
Participants
5,758 vs 32,035
Exposure
SHI vs cardiac surgery with same-day TEE
  • SHIn = 5,758
  • Cardiac surgeryn = 32,035reference
Outcome
Incidence proportion of upper gastrointestinal bleeding (UGIB)
Follow-up
Within 3 days postoperatively
Methodological detailsadministrative database
  • Administrative database

Main finding

As reported in the abstract

UGIB incidence proportion · within 3 days

Observational data: associations, not effects.

Further findings

Proportion of UGIB by day 7 presenting within 3 days

Associated factors

Prolonged anesthesia duration associated with increased upper gastrointestinal bleeding (UGIB) in both groups
Additional factors associated with UGIB differed by procedure type

In-hospital mortality, UGIB within 3 days vs no UGIB

SHI: UGIB vs no UGIB
20.0% v 1.3%
Cardiac surgery: UGIB vs no UGIB
8.5% v 4.5%

Original publication

Incidence and Associated Patient Characteristics of Gastrointestinal Bleeding Following Transesophageal Echocardiography in Transcatheter Structural Heart Interventions and Cardiac Surgery: A Descriptive Epidemiological Study. J Cardiothorac Vasc Anesth. Published 5 January 2026. doi:10.1053/j.jvca.2026.01.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.